Story
Stellantis Stock Falls After Morgan Stanley Downgrade on Product Pipeline Concerns
Summary
Morgan Stanley cut its rating on the automaker to 'Underweight,' citing a product lineup that lags competitors and growing pressure from inventory and sales incentives, which sent shares down over 2%.
Shares of Stellantis (STLA) fell more than 2% on Monday after Morgan Stanley downgraded the automaker to Underweight from Equal Weight, citing concerns that its vehicle pipeline is failing to keep pace with rivals.
Analyst Thesis
In a note to clients, Morgan Stanley analysts led by Javier Martinez de Olcoz Cerdan lowered their price target on Stellantis to $5.20 from a previous $8.00. The bank stated that negative trends in the company's inventory levels and sales incentives confirm its view that "the product pipeline is lagging behind peers."
This dynamic, according to the analysts, suggests Stellantis has limited capacity to reduce investments at a time when its cash generation is weakening. The firm described the automaker as having "the widest risk/reward skew in the sector," pointing to potential refinancing risks on one side and the possibility of asset sales or favorable USMCA renegotiations on the other.
European Sector Reassessment
The downgrade was part of a broader review of European automakers. In a contrasting move, Morgan Stanley upgraded France's Renault to Equal Weight from Underweight, citing its strong position in the European market and its potential to benefit from any regulatory actions against Chinese imports.
AdThe investment bank maintained its preference for premium manufacturers, keeping its Overweight ratings on both Mercedes-Benz and BMW. Morgan Stanley noted that while the cyclical bottom for industry margins is likely past, structural pressures are building, particularly from intensifying competition from Chinese electric vehicle makers.
Market Outlook
Morgan Stanley warned that consensus estimates still appear "too optimistic" regarding the level of investment required for European carmakers to close the cost and product gap with Chinese competitors. The bank expects both vehicle volumes and prices to continue declining through 2027.
Despite raising its 2026 and 2027 earnings estimates for the sector for the first time since April 2024, the firm believes margins are unlikely to recover to previous cycle highs. Key catalysts for the second half of 2026 include potential European tariffs on Chinese vehicles and capital markets day events from several automakers.
Read next
More on Stocks
Novo Nordisk, Orbis Medicines Ink $1.4 Billion Deal for Oral Cardiometabolic Drugs
Orbis Medicines and Novo Nordisk have entered a licensing collaboration potentially worth up to $1.4 billion to develop oral versions of injectable drugs for cardiometabolic diseases, leveraging Orbis's AI-driven discovery platform.
Robinhood Shares Rise After SEC Issues Guidance on Tokenized Securities
Shares of Robinhood Markets (HOOD) climbed after the U.S. Securities and Exchange Commission introduced a five-year plan allowing for the trading of tokenized stocks on designated venues.
Gold Prices Face Near-Term Pressure From Strong US Data, Higher Yields
Gold is trading in a narrow range as robust economic indicators bolster Treasury yields, creating headwinds for the non-yielding asset. The medium-term outlook remains constructive, contingent on a potential shift in monetary policy and persistent structural demand.
UBS Upgrades Industrial Metals to Overweight, Citing Long-Term Structural Tailwinds
UBS has raised its outlook on industrial metals to Overweight, arguing that structural forces like the energy transition and chronic underinvestment will support prices in the coming years.